Microbiota and Metabolomics of Intestinal Type of Gastric Cancer
NCT06079554 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 32
Last updated 2024-04-12
Summary
Compare with the gastric cavity without cancerous transformation in atrophic gastritis, analyze the microbiota and metabolomics changes in intestinal type of gastric cancer under the background of atrophic gastritis, and explore the relevant mechanisms.
Conditions
Sponsors & Collaborators
-
Jilin University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-31
- Primary Completion
- 2024-04-28
- Completion
- 2025-08-30
Countries
- China
Study Locations
More Related Trials
-
The Safety and Efficacy of PD-1 Monoantrapical Chemotherapy in the Treatment of Local Advanced Stomach Cancer
NCT05000554 ·Status: RECRUITING ·Phase: PHASE2
-
Study of Faecal Bacteria Detection in Early Screening and Diagnosis of GC
NCT04638959 ·Status: UNKNOWN
-
A Multifactor Prediction Model for Non-curative Outcomes in Mixed-type Early Gastric Cancer
NCT07096947 ·Status: COMPLETED
-
The Efficacy of Precision Treatment for Gastric Cancer Guided by Molecular Profiling
NCT04501887 ·Status: UNKNOWN
-
Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients
NCT06915389 ·Status: RECRUITING
-
the Optimal Surveillance Frequency for Stage II/III Gastric Cancer
NCT05465993 ·Status: COMPLETED
-
Resistance to Immunotherapy in Gastric Cancer
NCT03614013 ·Status: UNKNOWN
-
The First-line Combined Chemotherapy for Advanced Gastric Cancer: A Prospective Observational Clinical Study
NCT02583659 ·Status: UNKNOWN
-
The Construction of a Predictive Model for Gastric Cancer Immunotherapy Response Based on Tumor-Infiltrating Lymphocytes (TILs) and Histone H3K4me3 in the Tumor Microenvironment
NCT07069842 ·Status: RECRUITING
-
The Safety and Efficacy of Neoadjuvant Immunochemotherapy Followed by Laparoscopic Gastrectomy for Gastric Cancer
NCT06235164 ·Status: ACTIVE_NOT_RECRUITING
-
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
NCT03632746 ·Status: UNKNOWN
-
Relationship Between Standard Treatment Efficacy and The Tumor Microenvironment in Advanced Gastric Cancer
NCT04850716 ·Status: UNKNOWN
-
A Multicenter Study of Avapritinib Efficacy and Safety of Metastatic or Unresectable Gastrointestinal Stromal Tumors
NCT05464875 ·Status: RECRUITING
-
Prospective Evaluation and Molecular Profiling in People With Gastric Tumors
NCT03027427 ·Status: COMPLETED
-
Immune Checkpoint Inhibitors (ICIs) Retreatment in Second-line Treatment of Advanced Gastric Cancer: a Retrospective, Real-world Study
NCT06814548 ·Status: NOT_YET_RECRUITING
-
Genotype-drive Study of Irinotecan-Cisplatin Combination for Advanced Gastric Cancer
NCT01444521 ·Status: COMPLETED ·Phase: PHASE2
-
Predicting Biomarker of Gastric Cancer Chemotherapy Response
NCT03253107 ·Status: RECRUITING
-
Using Genetic Polymorphisms to Predict the Efficacy and Toxicity - A Gastric Adenocarcinoma Study
NCT01558011 ·Status: TERMINATED ·Phase: PHASE2
-
Transcriptomic Signatures in Gastric Adenocarcinoma
NCT05319392 ·Status: UNKNOWN
-
Methylation Analysis of Circulating Tumor DNA in Gastric Cancer
NCT04511559 ·Status: UNKNOWN
-
Genomic Evolution of Metastasis in Gastric Cancer
NCT05061082 ·Status: UNKNOWN
-
Comparing the Prognosis of Patients With Cardia and Non-cardia Gastric Cancer.
NCT03895008 ·Status: UNKNOWN
-
Machine Learning-driven Noninvasive Screening of Transcriptomics Liquid Biopsies for Early Diagnosis of Occult Peritoneal Metastases in Locally Advanced Gastric Cancer
NCT06478394 ·Status: RECRUITING
-
Defining Benchmarks for Gastric Cancer Patients Underwent Minimal Invasive Gastrectomy
NCT06938139 ·Status: ACTIVE_NOT_RECRUITING
-
Establishment of Serum Proteomics Subtypes of Gastric Cancer and Its Clinical Application
NCT06335576 ·Status: NOT_YET_RECRUITING